(Q37943826)

25 August 2017

title

Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management (English)

1 reference

25 August 2017

1 reference

1 reference

Ashima Makol

1

1 reference

25 August 2017

Kerry Wright

series ordinal

2

1 reference

25 August 2017

Shreyasee Amin

series ordinal

3

1 reference

25 August 2017

language of work or name

1 reference

1 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

71

1 reference

25 August 2017

issue

15

1 reference

25 August 2017

page(s)

1973-1987

1 reference

Pregnancy and rheumatoid arthritis: insights into the immunology of fetal tolerance and control of autoimmunity.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

The remission of rheumatoid arthritis during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Management of RA medications in pregnant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Aspirin and congenital malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Severe ductal constriction in the third-trimester fetus following maternal self-medication with nimesulide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Transfer of drugs and other chemicals into human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Anti-inflammatory and immunosuppressive drugs and reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Maternal corticosteroid use and orofacial clefts

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Accumulation of chorio-retinotoxic drugs in the foetal eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

The safety of antimalarial drugs in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Evidence of transplacental passage of hydroxychloroquine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: A study of one hundred thirty‐three cases compared with a control group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Antimalarial drugs in systemic lupus erythematosus: use in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Reversible male infertility due to sulphasalazine: studies in man and rat

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Azathioprine in rheumatoid arthritis: double-blind study of full versus half doses versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Teratogen update: azathioprine and 6-mercaptopurine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Azathioprine and breastfeeding-is it safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

The effects of methotrexate on pregnancy, fertility and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Methotrexate and misoprostol to terminate early pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Teratogenicity study of the dihydroorotate-dehydrogenase inhibitor and protein tyrosine kinase inhibitor Leflunomide in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Birth outcomes in women who have taken leflunomide during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Paternal and maternal exposure to leflunomide: pregnancy and neonatal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Certolizumab use in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Abatacept therapy and safety management

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Safety of rituximab therapy during the first trimester of pregnancy: a case history

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Pregnancy outcomes after maternal exposure to rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Tocilizumab: therapy and safety management

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Pregnancy outcome in women who were exposed to anti–tumor necrosis factor agents: Results from a national population register

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11596240-000000000-00000

Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents

21 January 2018

1 reference

12 December 2020

Pregnancy in inflammatory bowel disease: Effect of sulfasalazine and corticosteroids on fetal outcome

1 reference

12 December 2020

Placental Transfer of Sulphasalazine and Sulphapyridine and Some of Its Metabolites

1 reference

12 December 2020

Psoriasis, methotrexate, and oligospermia

1 reference

12 December 2020

Administration of rituximab during the first trimester of pregnancy without consequences for the newborn

1 reference

12 December 2020

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics

1 reference

12 December 2020

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

1 reference

12 December 2020

Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours

1 reference

12 December 2020

Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus

1 reference

12 December 2020

Secretion of methotrexate into human milk

1 reference

12 December 2020

THE OTOTOXICITY OF CHLOROQUINE PHOSPHATE.

1 reference

12 December 2020

Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis

1 reference

12 December 2020

Reversible congenital neutropenia associated with maternal sulphasalazine therapy

1 reference

12 December 2020

Bloody diarrhea--a possible complication of sulfasalazine transferred through human breast milk.

1 reference

12 December 2020

Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding).

1 reference

12 December 2020

The epidemiology of rheumatoid arthritis: a review. II. Incidence and diagnostic criteria

1 reference

12 December 2020

Prenatal exposure to prednisone in humans and animals retards intrauterine growth

1 reference

12 December 2020

Antimalarial drugs, pregnancy and lactation

1 reference

12 December 2020

The effect of Imuran on implantation and early embryonic development in rats

1 reference

12 December 2020

Pregnancy outcome of women exposed to azathioprine during pregnancy

1 reference

12 December 2020

Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis

1 reference

12 December 2020

Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial

1 reference

12 December 2020

Reversible Drug-Induced Sterility in a Patient With Acute Leukemia

1 reference

12 December 2020

Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases

1 reference

12 December 2020

Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy

1 reference

12 December 2020

Does rheumatoid arthritis remit during pregnancy and relapse postpartum?: Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy

1 reference

12 December 2020

The transplacental passage of prednisone and prednisolone in pregnancy near term

1 reference

12 December 2020

In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta

1 reference

12 December 2020

Hydroxychloroquine in pregnant patients with systemic lupus erythematosus

1 reference

12 December 2020

Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

1 reference

12 December 2020

Using an analogous monoclonal antibody to evaluate the reproductive and chronic toxicity potential for a humanized anti-TNFalpha monoclonal antibody

1 reference

12 December 2020

Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment

1 reference

12 December 2020

Retinal degeneration in 2 children following preventive antimalarial treatment of the mother during pregnancy

1 reference

12 December 2020

Prediction of risk for human developmental toxicity: how important are animal studies for hazard identification?

1 reference

12 December 2020

Maternal exposure to leflunomide associated with blindness and cerebral palsy

1 reference

12 December 2020

Pregnancy and rheumatoid arthritis

1 reference

12 December 2020

Efficacy and safety of a combined rituximab chemotherapy during pregnancy.

1 reference

12 December 2020

A patient's wish: anakinra in pregnancy

1 reference

12 December 2020

The effects of rituximab treatment during pregnancy on a neonate

1 reference

12 December 2020

Effects of an anti-TNF-alpha monoclonal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system

1 reference

12 December 2020

Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation

1 reference

12 December 2020

Etanercept in breast milk

1 reference

12 December 2020

Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies

1 reference

12 December 2020

Cyclosporine for rheumatoid arthritis

1 reference

12 December 2020

Teratogen update: reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child

1 reference

12 December 2020

The association between decreased amniotic fluid volume and treatment with nonsteroidal anti-inflammatory agents for preterm labor

1 reference

12 December 2020

Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun

1 reference

12 December 2020

Prednisolone excretion in human milk

1 reference

12 December 2020

10.2165/11596240-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

25 August 2017

1030921057

0 references

1 reference